Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company develops, manufactures, and markets assays that provide rapid therapeutic drug levels for essential and life-saving medicines prescribed by psychiatrists and oncologists. It provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracil. The company’s products are used in the treatment of cell lung cancer, digestive tract, prostate, and head and neck cancers. It markets its products in the US and abroad. Saladax is headquartered in Bethlehem, Pennsylvania, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Saladax Biomedical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Saladax Biomedical Inc Company Overview
- Saladax Biomedical Inc Company Snapshot
- Saladax Biomedical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Saladax Biomedical Inc - Pipeline Analysis Overview
- Saladax Biomedical Inc - Key Facts
- Saladax Biomedical Inc - Major Products and Services
- Saladax Biomedical Inc Pipeline Products by Development Stage
- Saladax Biomedical Inc Ongoing Clinical Trials by Trial Status
- Saladax Biomedical Inc Pipeline Products Overview
- MyCare Assay - Busulfan
- MyCare Assay - Busulfan Product Overview
- MyCare Assay - Busulfan Clinical Trial
- MyCare Assay - Cyclophosphamide
- MyCare Assay - Cyclophosphamide Product Overview
- MyCare Assay - Doxorubicin
- MyCare Assay - Doxorubicin Product Overview
- MyCare Assay - Gemcitabine
- MyCare Assay - Gemcitabine Product Overview
- MyCare Assay - Irinotecan
- MyCare Assay - Irinotecan Product Overview
- MyCare Assay - Lenalidomide
- MyCare Assay - Lenalidomide Product Overview
- MyCare Assay - Thalidomide
- MyCare Assay - Thalidomide Product Overview
- MyCare Assay - Tyrosine Kinase Inhibitor
- MyCare Assay - Tyrosine Kinase Inhibitor Product Overview
- MyCare Assay - Vincristine
- MyCare Assay - Vincristine Product Overview
- MyCare Insite
- MyCare Insite Product Overview
- MyCare Psychiatry Aripiprazole Assay Kit
- MyCare Psychiatry Aripiprazole Assay Kit Product Overview
- MyCare Psychiatry Olanzapine Assay Kit
- MyCare Psychiatry Olanzapine Assay Kit Product Overview
- MyCare Psychiatry Quetiapine Assay Kit
- MyCare Psychiatry Quetiapine Assay Kit Product Overview
- MyCare Psychiatry Total Risperidone Assay Kit
- MyCare Psychiatry Total Risperidone Assay Kit Product Overview
- Nanoparticle Immunoassay Kit - TDM
- Nanoparticle Immunoassay Kit - TDM Product Overview
- Saladax Biomedical Inc - Key Competitors
- Saladax Biomedical Inc - Key Employees
- Saladax Biomedical Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Saladax Biomedical Inc, Recent Developments
- Mar 15, 2022: Beckman Coulter introduces antipsychotic drug testing to address unmet clinical need for more than 69 million people living with serious mental conditions
- Feb 16, 2021: Saladax Biomedical announces Health Canada approval of five MyCare psychiatry laboratory diagnostic assay
- Dec 16, 2020: HLS Therapeutics announces update on Health Canada filings for MyCare
- Jul 08, 2020: Saladax Biomedical launches clozapine test in the US after FDA grants market authorization
- Jun 01, 2020: HLS Therapeutics to become distributor of the Saladax MyCare psychiatry line including the Insite point-of-care device and antipsychotic reagents
- Oct 24, 2019: Studies feature clinical validations of Clozapine point of care testing using a single drop of blood to aid psychiatrists in better treatment of patients with Schizophrenia
- Jul 25, 2018: Saladax Biomedical launches game-changing assays for psychotherapeutics at AACC 2018
- Jul 17, 2018: Saladax Submits for FDA Review a Rapid Blood Test for Levels of Risperidone
- Mar 21, 2018: Saladax Receives Approval to Sell a New Line of Psychiatry Tests on the European Market
- Dec 01, 2014: Saladax Biomedical Announces U.S. Launch of MyImatinib Chemotherapy Exposure Optimization Test
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Saladax Biomedical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Saladax Biomedical Inc Pipeline Products by Equipment Type
- Saladax Biomedical Inc Pipeline Products by Indication
- Saladax Biomedical Inc Ongoing Clinical Trials by Trial Status
- Saladax Biomedical Inc, Key Facts
- Saladax Biomedical Inc, Major Products and Services
- Saladax Biomedical Inc Number of Pipeline Products by Development Stage
- Saladax Biomedical Inc Pipeline Products Summary by Development Stage
- Saladax Biomedical Inc Ongoing Clinical Trials by Trial Status
- Saladax Biomedical Inc Ongoing Clinical Trials Summary
- MyCare Assay - Busulfan - Product Status
- MyCare Assay - Busulfan - Product Description
- MyCare Assay - Busulfan - Collection of Plasma Samples Using Sodium Heparin From Subjects Undergoing Intravenous Busulfan Treatment
- MyCare Assay - Cyclophosphamide - Product Status
- MyCare Assay - Cyclophosphamide - Product Description
- MyCare Assay - Doxorubicin - Product Status
- MyCare Assay - Doxorubicin - Product Description
- MyCare Assay - Gemcitabine - Product Status
- MyCare Assay - Gemcitabine - Product Description
- MyCare Assay - Irinotecan - Product Status
- MyCare Assay - Irinotecan - Product Description
- MyCare Assay - Lenalidomide - Product Status
- MyCare Assay - Lenalidomide - Product Description
- MyCare Assay - Thalidomide - Product Status
- MyCare Assay - Thalidomide - Product Description
- MyCare Assay - Tyrosine Kinase Inhibitor - Product Status
- MyCare Assay - Tyrosine Kinase Inhibitor - Product Description
- MyCare Assay - Vincristine - Product Status
- MyCare Assay - Vincristine - Product Description
- MyCare Insite - Product Status
- MyCare Insite - Product Description
- MyCare Psychiatry Aripiprazole Assay Kit - Product Status
- MyCare Psychiatry Aripiprazole Assay Kit - Product Description
- MyCare Psychiatry Olanzapine Assay Kit - Product Status
- MyCare Psychiatry Olanzapine Assay Kit - Product Description
- MyCare Psychiatry Quetiapine Assay Kit - Product Status
- MyCare Psychiatry Quetiapine Assay Kit - Product Description
- MyCare Psychiatry Total Risperidone Assay Kit - Product Status
- MyCare Psychiatry Total Risperidone Assay Kit - Product Description
- Nanoparticle Immunoassay Kit - TDM - Product Status
- Nanoparticle Immunoassay Kit - TDM - Product Description
- Saladax Biomedical Inc, Key Employees
- Glossary
- Saladax Biomedical Inc Pipeline Products by Equipment Type
- Saladax Biomedical Inc Pipeline Products by Development Stage
- Saladax Biomedical Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Diagnostics
- Dako North America Inc
- Advanced Diagnostics Inc
- Epic Sciences Inc
- ALPCO Diagnostics
